Biotech Cancels IPO While 3 Others Launch In Choppy Market
Biotechnology company ADC Therapeutics canceled its planned initial public offering while three other biotechnology startups debuted Thursday after pricing shares mostly at the lower end of their ranges in a shaky...To view the full article, register now.
Already a subscriber? Click here to view full article